The working meeting involved the development of a WHO guideline on screening for cardiovascular risk factors. Igho Onakpoya, Research Fellow in Evidence-based Practice and Pharmacovigilance, has spent the last few months synthesizing the evidence on the benefits and harms of CVD risk screening, which he presented at the meeting. Using GRADE methodology, the evidence presented, enabled the development of robust recommendations.
Professor Carl Heneghan chaired the meeting, which included a number of participants from across the globe. Centre staff have been working with the WHO over the last four years, working towards the WHO NCD Global Action plan.
The WHO Global NCD Action Plan 2013-2020 provides a road map to attain nine voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2025.
The CVD risk screening guideline should be available in early 2014.